To be malnourished or not to be malnourished: that is the question!
- PMID: 34795037
- DOI: 10.1183/13993003.02455-2021
To be malnourished or not to be malnourished: that is the question!
Conflict of interest statement
Conflict of interest: S. Jouneau reports fees, funding, or reimbursement for national and international conferences, boards, expert or opinion groups, and research projects over the past 5 years from Actelion, AIRB, AstraZeneca, Bellerophon Therapeutics, Biogen, BMS, Boehringer Ingelheim, Chiesi, FibroGen, Galecto Biotech, Genzyme, Gilead, GlaxoSmithKline, LVL, Mundipharma, Novartis, Pharm-Olam, Pfizer, Pliant Therapeutics, F. Hoffmann-La Roche, Ltd, Sanofi and Savara-Serendex, outside the submitted work. Conflict of interest: M. Kerjouan has nothing to disclose. Conflict of interest: R. Thibault has received royalties for designing the Simple Evaluation of Food Intake (SEFI) (Knoë, le Kremlin Bicêtre, France) tool, and consulting fees from F. Hoffmann-La Roche, Ltd.
Comment in
-
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem….Eur Respir J. 2022 Jan 13;59(1):2102820. doi: 10.1183/13993003.02820-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34795041 No abstract available.
Comment on
-
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis.Eur Respir J. 2021 Aug 19;58(2):2003345. doi: 10.1183/13993003.03345-2020. Print 2021 Aug. Eur Respir J. 2021. PMID: 33479108
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical